A detailed history of Clifford Swan Investment Counsel LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 242,987 shares of JNJ stock, worth $37.5 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
242,987
Previous 249,615 2.66%
Holding current value
$37.5 Million
Previous $36.5 Million 7.94%
% of portfolio
1.42%
Previous 1.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $964,241 - $1.11 Million
-6,628 Reduced 2.66%
242,987 $39.4 Million
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $143,946 - $157,306
-997 Reduced 0.4%
249,615 $36.5 Million
Q1 2024

Apr 16, 2024

SELL
$155.22 - $162.74 $766,786 - $803,935
-4,940 Reduced 1.93%
250,612 $39.6 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $19,947 - $21,766
-137 Reduced 0.05%
255,552 $40.1 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $325,361 - $364,488
-2,089 Reduced 0.81%
255,689 $39.8 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $86,590 - $93,187
-561 Reduced 0.22%
257,778 $42.7 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $245,909 - $293,463
-1,628 Reduced 0.63%
258,339 $40 Million
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $1.18 Million - $1.32 Million
-7,363 Reduced 2.75%
259,967 $45.9 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $1.07 Million - $1.19 Million
-6,605 Reduced 2.41%
267,330 $43.7 Million
Q2 2022

Aug 04, 2022

SELL
$168.19 - $186.01 $296,182 - $327,563
-1,761 Reduced 0.64%
273,935 $48.6 Million
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $145,330 - $165,043
-919 Reduced 0.33%
275,696 $48.9 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $48,962 - $54,325
-314 Reduced 0.11%
276,615 $47.3 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $520,514 - $578,431
-3,223 Reduced 1.15%
276,929 $44.7 Million
Q2 2021

Aug 05, 2021

SELL
$159.48 - $171.07 $787,193 - $844,401
-4,936 Reduced 1.73%
280,152 $48.6 Million
Q1 2021

May 07, 2021

SELL
$153.07 - $170.48 $82,351 - $91,718
-538 Reduced 0.19%
285,088 $46.9 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $603,969 - $693,258
-4,405 Reduced 1.52%
285,626 $45 Million
Q3 2020

Oct 30, 2020

SELL
$140.38 - $153.83 $159,892 - $175,212
-1,139 Reduced 0.39%
290,031 $43.2 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $229,925 - $277,585
-1,785 Reduced 0.61%
291,170 $40.9 Million
Q1 2020

Apr 09, 2020

SELL
$111.14 - $153.99 $294,187 - $407,611
-2,647 Reduced 0.9%
292,955 $38.4 Million
Q4 2019

Jan 30, 2020

SELL
$127.5 - $146.44 $87,847 - $100,897
-689 Reduced 0.23%
295,602 $43.1 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $267,737 - $299,773
-2,109 Reduced 0.71%
296,291 $38.3 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $578,502 - $636,242
-4,411 Reduced 1.46%
298,400 $41.6 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $414,498 - $460,887
-3,297 Reduced 1.08%
302,811 $42.3 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $151,584 - $182,434
1,234 Added 0.4%
306,108 $39.5 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $313,797 - $368,773
-2,581 Reduced 0.84%
304,874 $42.1 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $442,257 - $488,039
3,704 Added 1.22%
307,455 $37.3 Million
Q1 2018

May 09, 2018

SELL
$125.1 - $148.14 $361,038 - $427,532
-2,886 Reduced 0.94%
303,751 $38.9 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $1.63 Million - $1.78 Million
12,416 Added 4.22%
306,637 $42.8 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $1.98 Million - $2.07 Million
-15,314 Reduced 4.95%
294,221 $38.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
309,535
309,535 $40.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.